Pharmaceuticals AI Solutions
Data analysis for research and regulatory documentation processing automation.
Talk to Zech, live

- Pharmaceutical Manufacturers
- Biotechnology Companies
- Generic Drug Companies
- Contract Research Organizations
- Medical Affairs Organizations
Pharma companies have to deal with extensive research data, scientific information, regulatory documents, quality records, study materials, and operational data. The search for information, the extraction of useful data, comparison of documents or the transfer of information in review processes may be a high investment of time.

ZechionAI supports pharmaceutical and life-sciences companies in solving these real-world problems by leveraging AI, data engineering, document automation, analytics, knowledge systems, and workflow automation.
Our solutions can facilitate teams to organize research information, analyze approved information, process complex documents, extract structured information, enhance enterprise search, automate repetitive business procedures, and integrate AI capabilities with existing technology environments.
It's not meant to be used in place of pharmaceutical knowledge. The aim is to provide good teams with better technology in what they do.
The AI Solutions designed with pharmaceutical workflows in mind
7 services
AI has unique needs within the pharmaceutical sector compared to other industries. Research information can be subject to scientific interpretation. Controlled review might be a requirement in regulatory documents. Qualified assessment of safety information may be needed. Documented processes and approvals may exist for quality records.
ZechionAI works with these facts.
Our pharmaceutical AI engagements can incorporate:
- Human-in-the-loop review
- Role-based access
- Controlled data sources
- Document version awareness
- Audit logging
- Data lineage
- Validation and evaluation
- Approval workflows
- Exception handling
- Model monitoring
- Access governance
- Secure integrations
- Change management
- Documentation and traceability
AI can find, sort, summarize, categorize, compare or route information. Science, medical, regulatory, safety and quality and other regulated decisions continue to be the responsibility of qualified professionals.
AI can help Pharmaceutical Organizations in several key areas

AI can benefit Pharmaceutical Organizations in multiple important ways:
There are a number of pharmaceutical companies that hold information in research, clinical development, regulatory, pharmacovigilance, quality, manufacturing, medical affairs, commercial and corporate systems.
Teams can find themselves in the following situations:
- Large research datasets
- Structured and unstructured information.
- Scientific publications
- Clin. and Preclin. documents
- Study reports
- Strictly speaking, regulatory submissions and supporting documents are of paramount importance to an entrepreneur's company.
- Regulatory correspondence
- Safety documentation
- SOPs
- Technical reports
- Quality documentation
- Product information
- Spreadsheets and PDFs
- Scanned records
- Fragmented repositories
- Inconsistent metadata
- Duplicate information
- Manual extraction processes
- Repetitive document review
- Difficult information retrieval
- Long workflow cycles
- Data-quality exceptions
- Several systems with related information
These are the types of workflows that ZachationAI can work with in designing technology, not forcing teams to give up their current technology.
Research Data Analysis

Research Data Organization
- Data ingestion
- Data normalization
- Metadata extraction
- Data classification
- Data-quality checks
- Duplicate detection
- Dataset organization
- Research repository organization
- Data profiling
- Schema mapping
- Data cataloging
- Data lineage support
Potential capabilities include:
The solutions can be designed to complement the organization's data sources, access policies, validation requirements, and technical environment.
Convert Research Information into Structured and Useful Data
Research teams can be comprised of people from across datasets, reports, publications, study documents, spreadsheets, databases, and internal repository. Organizing and analyzing approved information with ZechionAI can reduce the time spent on repetitive preparations and retrievals for teams.
Research Analytics
ZechionAI can support:
- Descriptive analytics
- Diagnostic analytics
- Predictive Analytics: When applicable, use predictive analytics to forecast data and trends.
- Trend analysis
- Correlation analysis
- Cohort analysis
- Comparative analysis
- Time-series analysis
- Outlier identification
- Pattern detection
- Research dashboards
- Automated reporting
- Data visualization
The results of analysis should be compared with the purpose of the analysis, the data quality, the analytical method, and Scientific controls that are applicable. While AI analysis is a valuable tool, it cannot replace scientific expertise.
Research Information Extraction
Structured information can be extracted using AI from:
- Research reports
- Scientific publications
- Study documents
- Technical reports
- Experimental records
- Tables
- PDFs
- Spreadsheets
- Structured databases
- Approved internal repositories
The information retrieved can then be fed into databases, review queues, analytics systems, knowledge repositories or downstream processes, as they are technically supported and authorized.
The clinical and study data support

Structure Study Information; Do not replace clinical judgment.
- Study data organization
- Dataset classification
- Data-quality workflows
- Study document processing
- Protocol document analysis
- Structured extraction
- Data reconciliation support
- Study metadata management
- Research reporting
- Controlled information retrieval
- Study document comparison
- Research repository search
ZechionAI can offer technologies support for study information management and analysis.
Potential applications include:
The technology can be used to help recognize patterns, to organize information, and to aid in reporting. It is not a decision maker for clinical effectiveness, safety, clinical or regulatory conclusions.
Regulatory Document Processing Automation

Document Intake
- Upload and ingestion
- Document classification
- Metadata extraction
- Version identification
- Duplicate detection
- Document routing
- Repository indexing
- Workflow assignment
There are several types of regulatory documents that can be part of a regulatory document workflow:
Minimize repetitive work throughout regulatory documents
Regulatory organizations might have a large number of submissions, correspondence, reports, supporting documents, references and product-related information.
ZechionAI can create a workflow for processing documents that can classify, extract, compare, search, summarize, and route information while maintaining qualified reviewers' control.
Document Understanding
AI can help with the identification of:
- Document type
- Product references
- Study references
- Dates
- Organizations
- Regulatory topics
- Sections
- Tables
- Key statements
- References
- Required fields
- Potentially missing information
- Repeated information
The information retrieved may be provided to reviewers for checking prior to its application in downstream processes.
Regulatory Document Workflows
Potential workflows include:
- Regulatory correspondence processing
- Submission document organization
- Metadata extraction
- Document comparison
- Version comparison
- Content identification
- Analytical research support for regulation and regulatory affairs.
- Review task routing
- Controlled document summarization
- Regulatory repository search
- Reporting automation
- Document completeness support
These workflows are designed to assist regulatory professionals, but do not make regulatory decisions or ensure regulatory results.
Regulatory Submission Support

AI or automation can help the regulatory teams organize information in advance, before qualified professionals go over it for review and approval.
Potential capabilities include:
- Submission document organization
- Content indexing
- Metadata extraction
- Document completeness checks
- Cross-document comparison
- Version tracking
- Reference identification
- Structured information extraction
- Review workflow routing
- Submission preparation support
- Regulatory correspondence organization
- Searchable regulatory repositories
Final submission, regulatory decision, approval, interpretation, sign-off continue to be the responsibility of suitably qualified staff.
Regulatory Knowledge Assistant

Search Approved Regulatory and Organizational Information
- SOPs
- Regulatory documents
- Research documents
- Quality documentation
- Technical documents
- Approved product information
- Internal policies
- Training materials
- Regulatory correspondence
- Controlled repositories
ZechionAI can develop controlled knowledge assistants that can fetch info from authorized organizational resources.
Knowledge sources that could be used are:
Knowledge Assistant Capabilities
A controlled pharmaceutical knowledge assistant can be used to deliver:
- Natural-language search
- Question answering
- Document retrieval
- Source-aware responses
- If enabled, displays citations or references.
- Role-based knowledge access
- Document version awareness
- Knowledge-base refresh
- Human review workflows
- Audit logging
- Monitor search history and usage (where appropriate)
The assistant can be set to search only authorized information. It must not create regulatory requirements, make assumptions that are not supported and give an unconfirmed answer as a definite conclusion.
Retrieval-Augmented Generation With Controlled Sources (RAGWCS)

Retrieval-Augmented Generation (RAG) is a technique that links an AI model to a curated set of reliable data sources.
Pharmaceutical RAG Applications
- Regulatory knowledge bases
- Research repositories
- SOP assistants
- Quality knowledge systems
- Information technology in medical affairs.
- Technical documentation
- Internal policy repositories
- Enterprise document search
- Product information retrieval
This is a typical pharmaceutical RAG workflow:
The relevant context is the key component of the chain, determining whether the AI's response is useful.
The system does not simply use the general knowledge that has been programmed into the model and instead fetches the relevant content from configured repositories where it can offer that content as context to the response generation.
RAG can support:
RAG can be helpful in improving source grounding and provide for easier review of responses, yet it cannot prevent incorrect or unsupported output. The quality of the source material, the configuration for retrieval, configuration of the behavior of the model, permissions, and human review are important.
AI Agents for pharmaceutical workflows
AI Agents for pharmaceutical workflows.
Agents with specific permissions for specific tasks
ZechionAI can create AI agents to execute specific workflows and tasks.
Agents can be restricted by:
- Data source
- User role
- Department
- Document type
- Workflow stage
- Available tools
- Approval requirements
- System permissions
Research Data Agent
Organizes, classifies, analyzes and summarizes approved research data sets
Regulatory Document Agent
Organizes, retrieves, directs, and summarizes regulatory documents based on workflows.
Regulatory Knowledge Agent
Consults legal and institutional sources of knowledge in an approved manner.
Document Review Agent
Finds out details, fields, sections or human verification requirements.
Research Reporting Agent
Supports periodic research reporting, data summarization and reporting processes.
Data Quality Agent
Locates possible missing, inconsistent or duplicated or anomalous data for further review.
Compliance Documentation Agent
Supports documented and evidence-based processes.
Medical Affairs Knowledge Agent
Delivers safe access to medical affairs information sources.
Workflow Coordination Agent
Routes documents, tasks, notifications and review activities based on defined rules.
The agents are to act within delegated authority limits and are not to be independent in making regulated medical, safety, scientific, regulatory or quality decisions.
Pharmacovigilance AI Support
Support and improve Safety Workflows with the right human review
In selected pharmacovigilance workflows, AI can help, provided there are suitable workflows, data and validation processes, and operating procedures.
Potential applications include:
- Case intake support
- Document classification
- Safety information extraction
- Duplicate-case identification support
- Literature screening support
- Case routing
- Structured data extraction
- Workflow prioritization
- Reporting preparation support
The capabilities should be based on the processes and requirements that have been validated within the organisation.
AI should not be used to make final medical determination, to decide if the case is valid, to decide on the report, or to take the place of qualified health safety personnel.
Pharmaceutical Quality Documentation Support
Ensure that all compliance and quality requirements are met
Collate Quality Information and minimise repetitive document work
ZechionAI can help with technology processes related to the documentation of quality and control information.
Potential applications include:
- SOP classification
- Controlled document search
- CAPA documentation support
- Deviation documentation support
- Audit preparation support
- Training document organization
- Quality reporting
- Document version control
- Quality information retrieval
- Workflow routing
- Documentation review support
The control(s) necessary will vary based on the organization's quality system, intended use, validation requirements, and applicable regulations.
ZechionAI does not guarantee that the implementation of a technology is automatically compliant or certified, just because it uses AI or automation.
Pharmaceutical Document AI
Document AI is a combination of document processing, machine learning, natural-language processing, OCR, document extraction, classification, and workflow automation.
Increase the consistency of process documents.
- 01
OCR
Retrieve Text from scanned documents and image-based records.
- 02
Classification
Recognize document categories and process documents based on rules defined.
- 03
Information Extraction
Identify and extract structured fields, references, dates, identifiers, sections, tables and other specified information.
- 04
Comparison
Compare versions of a document and mark changes for the attention of a reader.
- 05
Summarization
Create controlled paragraph summaries to facilitate reviewers' review in large documents.
- 06
Routing
Send documents or extracted information to the appropriate workflow, repository, or review queue.
- 07
Validation Support
Mark any possible missing, inconsistent or exceptions that need to be reviewed by humans.
- 08
Search
Build searchable repositories of authorized documents and sources of information.
The quality of documents, data, model configuration, workflow design and validation all affect the performance of document processing. However, human intervention is still crucial for more critical applications.
Pharmaceutical Data Integration
Integrate AI into current technologies.
Integrate AI systems into the current technologies.
ZechionAI can create integrations with accepted systems and data sources as long as such action is technically supported and authorized.

Potential environments include:
- Research databases
- Clinical data repositories
- Laboratory systems
- LIMS
- Systems to capture data electronically.
- Document management systems
- Quality management systems
- The information management systems used in regulation.
- ERP systems
- CRM platforms
- Data warehouses
- Data lakes
- Cloud storage
- Internal APIs
- Approved external datasets
- Scientific literature sources
Architectures are dependent on the current environment, security needs, data ownership, integration needs and intended use.
Pharmaceutical AI Analytics
From Reporting to Decision Support
ZechionAI can assist organizations with four levels of analytics.
Descriptive Analytics
What happened?
Be familiar with historical activity, volumes, trends, distributions and operational patterns.
Diagnostic Analytics
How can it be accounted for?
Discuss relationships and exceptions, changes and possible contributing factors.
Predictive Analytics
What may happen?
Apply the correct models to make estimates for future patterns or results from existing data.
Prescriptive Analytics
What would be possible options?
Share solutions or scenarios with potential solutions for qualified professionals to consider.
In the pharmaceutical sector, analytics should be conducted under suitable scientific, clinical, quality, security and regulatory conditions.
The AI Services for Pharmaceuticals solution comprises all the necessary components
AI Strategy & Advisory
- AI readiness assessment
- Use-case discovery
- Data-readiness assessment
- Technology assessment
- AI roadmap development
- Business-case development
- Governance planning
- Architecture planning
- Pilot prioritization
AI Development
- Machine learning
- Predictive analytics
- Natural-language processing
- Document AI
- Classification
- Information extraction
- Recommendation systems
- Custom AI applications
- AI workflow applications
Pharmaceutical Data Engineering
- Data pipelines
- Data integration
- Data normalization
- Data-quality workflows
- Data warehouses
- Data lakes
- Metadata management
- Data catalogs
- API integration
- Data lineage support
Research Analytics
- Research data analysis
- Dataset analysis
- Trend analysis
- Pattern detection
- Comparative analysis
- Research reporting
- Visualization
- Predictive modeling
- Data-quality analysis
Regulatory Document Automation
- Document classification
- Information extraction
- Metadata processing
- Document comparison
- Version comparison
- Summarization
- Document routing
- Regulatory correspondence processing
- Search
- Workflow automation
RAG & Knowledge Systems
- Regulatory knowledge assistants
- Research assistants
- SOP assistants
- Quality knowledge systems
- Technical knowledge assistants
- Medical affairs knowledge systems
- Controlled enterprise search
AI Agents & Workflow Automation
- Research agents
- Regulatory document agents
- Reporting agents
- Data-quality agents
- Knowledge agents
- Workflow agents
- Document-processing agents
AI Integration
- APIs
- Enterprise applications
- Data platforms
- Document repositories
- Internal systems
- Cloud environments
- Workflow platforms
- Existing business applications
AI Governance
- AI inventory
- Access controls
- Model documentation
- Evaluation
- Monitoring
- Auditability
- Human oversight
- Change management
- Risk controls
- Data governance
Managed AI Services
- AI monitoring
- Model maintenance
- Knowledge-base maintenance
- Workflow maintenance
- Optimization
- Technical support
- Performance reviews
- Integration support
- Governance support
Pharma AI Use Cases
Research & R&D
- Research data analysis
- Research document classification
- Scientific literature analysis
- Research knowledge assistants
- Dataset quality analysis
- Research trend analysis
- Study document extraction
- Research reporting automation
- Research repository search
- Experimental-data organization
Regulatory
- Regulatory document classification
- Regulatory metadata extraction
- Regulatory document comparison
- Submission document organization
- Regulatory correspondence processing
- Regulatory knowledge search
- Submission completeness support
- Regulatory reporting automation
- Regulatory reference identification
- Version tracking for regulatory documents.
Pharmacovigilance
- Literature screening support
- Safety information extraction
- Case intake support
- Duplicate detection support
- Case routing
- Safety document classification
- Safety-data extraction
- Pharmacovigilance workflow prioritization
Quality
- SOP classification
- Quality document search
- CAPA documentation support
- Deviation documentation support
- Audit preparation support
- Quality reporting
- Quality-document comparison
- Training documentation organization
Medical Affairs & Commercial
- Medical knowledge assistants
- Approved content search
- Field inquiry classification
- Information flow support for medical information.
- Content analysis
- Reporting automation
- Medical-information repository search
Controlled internal knowledge retrieval is the ability to retrieve knowledge without relying on external cues.
Enterprise
- Enterprise knowledge assistants
- Document workflow automation
- Data-quality monitoring
- AI reporting agents
- Workflow orchestration
- Executive analytics
- Enterprise document search
- Cross-system information retrieval
- Automated metadata management
- Department-specific knowledge systems
- AI-assisted operational reporting
Solutions based on Pharmaceutical Organization Type
Pharmaceutical Manufacturers
For manufacturers, connected systems can provide a benefit in regulatory documentation, quality information, research analytics, knowledge management, document processing and enterprise reporting.
Potential priorities include:
- Regulatory workflows
- Quality documentation
- Research analytics
- Knowledge systems
- Data integration
- Document automation
- Enterprise analytics
Biotechnology Companies
Research programs, data environments, documentation needs change in Biotechnology organizations, which can require flexible technology.
Potential priorities include:
- Research data organization
- Scientific literature analysis
- Research knowledge systems
- Study-document processing
- Data engineering
- Regulatory documentation support
Specialty Pharmaceutical Companies
Specialty organizations can deal with intricate product knowledge, medical affairs processes, regulatory documentation, knowledge retrieval, and operational analytics.
Generic Drug Companies
Potential applications include:
- Regulatory document processing
- Submission support
- Document comparison
- Research information management
- Knowledge systems
- Quality documentation
- Data analytics
Contract Research Organizations
A CRO can control information across various studies, sponsors, systems and document collections.
Examples of technologies include:
- Study document processing
- Data-quality workflows
- Research analytics
- Document classification
- Reporting automation
- Knowledge retrieval
- Workflow orchestration
CDMOs can have technical documentation, quality information, manufacturing data, analytics, document processing and enterprise knowledge technology requirements.
Medical Affairs Organizations
Potential priorities include:
- Approved information retrieval
- Medical knowledge systems
- Inquiry classification
- Content search
- Reporting
- Controlled knowledge assistants
Regulatory Consulting Organizations
AI and automation can help regulatory consulting teams organize documents, conduct research, compare documents, extract information and retrieve knowledge.
Life-Sciences Technology Organizations
Life science technology providers can partner with ZechionAI for:
- AI engineering
- Data engineering
- Document AI
- RAG
- AI agents
- Integrations
- Analytics
- Workflow automation
- Managed AI services
Security & Privacy
Managing access to data is essential to pharmaceutical AI.
Confidential research, proprietary information, regulated documentation, personal information and other sensitive business data may be found in pharmaceutical technology environments.
Responsible AI for Pharmaceuticals
Install safeguards on the technology
From the outset, pharmaceutical AI should be designed with the necessary controls.
ZechionAI can incorporate:
- Human oversight
- Validation
- Traceability
- Explainability where appropriate
- Model evaluation
- Data lineage
- Version control
- Access governance
- Change management
- Monitoring
- Audit trails
- Controlled deployment
- Appropriate documentation
- Exception handling
- Output review
Do not assume that AI-generated content is or is not, by itself, a regulatory, medical, scientific, safety or quality determination.
The appropriate level of review will depend on the intended use, the risk, data, workflow and applicable requirements.
Human-in-the-Loop
AI Assists. Professionals Decide.
One of the fundamental concepts of ZechionAI's pharmaceutical solutions is human oversight.
One of the most common controlled workflows is:
With the help of AI, the system records the action and allows for professional reviews when approved by the authorized person.
This model can be used with workflows including:
- Regulatory document review
- Safety information review
- Research interpretation
- Quality documentation
- Submission preparation
- Data anomaly review
- Document classification exceptions
- Extracted-information verification
The goal is to assist in making repetitive work more automated, but retain proper professional accountability.
ZechionAI Pharmaceutical AI Implementation Lifecycle
The journey to discovering, strategizing, designing, building, integrating, deploying, automating, monitoring, securing, governing, optimizing, and scaling your infrastructure is never easy.
- 01
Discover
Obtain information about the business problem, flow, users, data, systems, business constraints, and desired outcome.
- 02
Strategize
Focus on the opportunities that make sense, are achievable, are not too risky, have sufficient data, and are fit for the organization.
- 03
Design
Outline the structure, process, data sources, access, user experience, review controls, and assessment process.
- 04
Build
Create the AI application, models, document process, integrations, data pipelines or knowledge systems.
- 05
Integrate
Link solution to approved enterprise systems and repositories as technically supported and authorized.
- 06
Deploy
Implement approved solution in designated environment(s) with access and operational controls established.
- 07
Automate
Ensure that repetitive tasks are automated with needed exception handling and oversight.
- 08
Monitor
Monitor system behaviour, performance, exceptions, usage, data changes and operational problems.
- 09
Secure
Implement secure access, privacy, infrastructure and data controls.
- 10
Govern
Keeping documentation, evaluation, permissions, change management, auditability and oversight.
- 11
Optimize
Optimize workflows, retrieval, models, integrations, usability and operational performance by leveraging evidence.
- 12
Scale
Expand successful implementations to other workflows, departments, datasets, or business units, as appropriate.
Why Outsource Pharmaceutical AI Development?
Specialized technology that is not built in-house
While outsourcing might be a viable solution for some pharmaceutical firms, it is not necessarily the best fit for all. The right model will depend on the risk, technology architecture, the project scope, and the long-term plans for operations.
An external partner from the AI engineering field can supply:
- 01
Specialized AI Engineering
Expert access to AI development, NLP, document AI, data engineering, RAG, analytics and AI agents.
- 02
Faster Experimentation
Assess a specific use case without establishing an internal team right away.
- 03
Reduced Development Burden
Add internal technology resources when teams have a lot of priorities.
- 04
Multi-System Integration
Integrate data, document, workflow and application engineering skills.
- 05
Document AI Expertise
Construct workflows to classify, extract, compare, summarize, search, and route.
- 06
Data Engineering Support
Create, combine, and shape data needed for AI applications.
- 07
RAG and Knowledge-System Expertise
Establish controlled access to approved organizational information.
- 08
Flexible Capacity
Include technical resources for pilots, implementation projects or current support.
- 09
Independent Technical Perspective
Assess current workflows and technology decisions from an engineering outsider's point of view.
- 10
Ongoing Optimization
Improve implementation post deployment.
- 11
Focused Starting Point
Start with one clear workflow process and not an organisation-wide roll-out.
Why is it worth to partner with ZechionAI?
- 01
One Technology Partner
Concentrate AI Strategy, Engineering, Data, Integration, Automation, Analytics, Governance and Managed Services.
- 02
Start Small
Start with one workflow, documented process, dataset, knowledge system and/or analytics use case.
Coordinate with existing systems:
If possible, base the design on existing infrastructure and applications.
- 03
Human Review Built Into Workflows
Continue using qualified professionals as necessary for interpretation, approval and/or regulated decisions.
- 04
Practical AI
Prioritize addressing specific operational and information-management issues instead of just implementing AI technologies for the sake of having them.
- 05
Flexible Engagement
Engage in transition from assessment to pilot to production and expansion, as evidence and experience are accumulated.
- 06
Long-Term Support
Monitoring/
optimization, governance, maintenance of knowledge-base, integration support, technical maintenance as needed.
Pharmaceutical AI Engagement Models
ZechionAI can define engagements based on the needs of the project and not just one specific engagement model.
These are some of the options that can be taken:
- 01
AI Readiness Assessment
Assess workflows, data, systems, use cases, risks and opportunities.
- 02
Focused AI Pilot
Evaluate one specific workflow with measurable criteria.
- 03
Project-Based Implementation
Create and develop an AI-driven, production-based application or automation process.
- 04
Monthly AI Services
Conduct continuous engineering, analytics, integration, maintenance or optimization support.
- 05
Managed AI Services
Provide support to deployed systems via monitoring, maintenance, governance and continuous improvement.
Typically, pricing depends on scope, complexity of data, integrations, deployment needs, number of workflows, number of users, security needs, and governance needs.
Measuring AI Value
Set up a baseline prior to measuring improvement
ZechionAI does not guarantee a specific level of ROI or savings.
A baseline measurement should be set up for each implementation and performance should be compared after implementation.
Possible KPIs include:
- Processing time
- Manual effort
- Document turnaround time
- Data-quality exceptions
- Search time
- Workflow cycle time
- Review workload
- Classification performance
- Extraction performance
- User adoption
- Automation rate
- Exception rate
- Model performance
- Cost per processed document
- Reporting time
A baseline agreement is essential for measuring the value of AI.
For regulated workflows, quality and control measures may be as important as speed or cost.
Start Small. Scale Responsibly
- 01
Assess
Know the process, information, participants, systems, threats and results.
- 02
Pilot
Test one well-defined use case with illustrative data.
- 03
Validate
Analyze performance through testing, human evaluation and acceptance criteria.
- 04
Deploy
Transfer approved workflow to target production environment.
- 05
Monitor
Monitor usage, exceptions, data modification and operational behavior.
- 06
Expand
Implement more workflows where they provide value and are operationally ready when they have been tested in the initial implementation.
ZechionAI is not a panacea for every problem
ZechionAI is not a magic bullet for all issues.
Good pharmaceutical AI companies must be transparent about their restrictions.
ZechionAI does not promise:
- Guaranteed regulatory approval
- Guaranteed clinical outcomes
- Guaranteed compliance
- 100% AI accuracy
- Complete autonomy in decision making within the regulation.
- Substitution of the regulatory staff.
- Replacement of medical or scientific judgment,
- Guaranteed financial savings
Results may vary based on:
- Data quality
- System integration
- Workflow design
- Model selection
- Validation
- Human review
- Organizational adoption
- Regulatory requirements
- Deployment environment
- User behavior
- The condition of the source documents.
The right answer should aim to fit the problem and not a blanket expectation that automation cannot be avoided.
AI services for Pharmaceuticals
ZechionAI offers AI strategies, AI development, research analytics, pharmaceutical data engineering, document AI, automated regulatory documents, RAG and knowledge systems, AI agents, integrations, governance, and managed AI services.
Yes. ZechionAI can create workflows to organize, normalize, analyze, visualize and report approved research datasets. The analytical results need to be interpreted and validated accordingly by qualified experts.
Yes. AI can help you with ingesting documents, classify documents, extract metadata, extract information, compare documents, summarise, search and route documents. The right process is dependent on the kind of document and intended use.
Yes. A document-classification workflow can classify documents according to rules, models and approved training or reference data, and exceptions from the workflow are taken for human review.
Yes. Document AI supports OCR for digital PDFs and as needed, scanned PDFs. The quality of the extraction will be influenced by the structure of the documents, the quality of the scan, the language of the documents, formatting, and the model configuration.
Yes. ZechionAI is capable of creating comparison workflows to detect differences between versions and show them for subsequent review.
Yes. AI can generate summaries to assist users in reading long documents. Summaries are not intended to be regulatory interpretations, but instead should serve as a review tool.
Yes. ZechionAI can develop controlled knowledge assistants that are linked to approved regulatory documents, internal policies, SOPs, correspondence, technical information or other approved repositories.
RAG is an acronym for Retrieval-Augmented Generation. Fetches relevant data from the configured sources and delivers it to an AI model to use for generating a response.
Yes. A well-designed RAG system can pull data from documented SOP repository, honoring access and document versions.
Yes, if a suitable technical integration or approved data-access method is offered by the repository. Additionally, the solution needs to adhere to organizational permissions and data-use requirements.
On theoretical grounds it is possible where it is technically designed and authorised. The integration can be achieved through APIs, approved connectors, databases, middleware or other interfaces that may be available in the environment of the LIMS.
Yes. Once the API, credentials, permissions and the architecture are in place, they can be used to integrate AI applications with the existing enterprise system.
Yes. AI can support areas such as document classification, literature screening, information extraction, case intake support, routing, and duplicate-identification support. Qualified safety professionals are still responsible for making "judicious" assessments and decisions.
Yes. AI can help in literature discovery, classification, screening, literature extraction and prioritization. There may still be a need for human review, especially if the screening has safety, scientific, or regulatory importance.
AI can help find and pull out relevant safety data from sources, which are configured. Identification does not result in a final safety assessment or case determination.
No. ZechionAI offers technology for the support of regulatory professionals. The qualified staff members are still accountable for the interpretation, decisions, submission and approval of regulations.
No. ZechionAI's solutions should be created with the purpose of helping to make decisions within a set of well-defined workflows, not making decisions on their own.
A typical workflow for the AI would be for it to do a defined task, present the output to an authorised individual, have that person review or modify what it has produced and record the action taken as appropriate.
Security can mean data segregation, secure APIs, monitoring, controlled access, RBAC, audit logging, environment separation, and encryption. The selection of specific controls should be based on the requirements of the organisation.
It is possible, depending on the architecture, infrastructure, models, integrations and security requirements selected. During solution design, deployment options should be considered.
Yes, as long as the chosen technology architecture enables hybrid deployment. Each component can run in an approved cloud, private or on-premises environment, depending on technical and security requirements.
AI governance may encompass use case approval, access to data, model documentation, evaluation, permissions, monitoring, auditability, change management, human oversight and lifecycle controls.
The decision to evaluate should be based on the use case. This can be the efficiency of classification, the accuracy of the extracted data, the quality of the retrieved data, the quality of the response, the number of exceptions, results of the human review, and other specified acceptance criteria depending on the workflow.
Yes. If the underlying architecture of RAG and document-retrieval systems allows it, source documents, passages, citations, or references can be displayed.
A system can be engineered to relate content to versions of documents and metadata. The implementation should take into consideration the organization's document-management and governance needs.
Yes. OCR is used to transform documents that are captured by the camera into machine-readable text before they are processed by downstream classifiers and extractors. If the scan is not done properly, it could affect the quality of the extraction.
Yes. Tables can be detected and retrieved as part of a document-processing systems design. For complex layouts, a special process and manual verification may be necessary.
A configured rule and context can be used to identify potentially missing fields, sections, metadata, references, or information that can be flagged by AI. Items that are flagged should be looked at, not assumed to be confirmed deficiencies.
Yes. AI and traditional workflow automation can gather approved content, create a structured summary, fill in reports and send out content for review.
Yes. SOP search, document classification, quality-document processing, CAPA documentation support, deviation-document support, audit preparation and quality reporting are just a few examples of the potential applications.
Yes. Controlled knowledge systems can be used in approved information retrieval, inquiry classification, content search, reporting, and for other well-defined workflows in medical affairs teams.
Yes. Depending on the client's needs and the access of available data, CROs may use AI to process study documents, organize research information, extract data, report results, perform data-quality workflows, and retrieve knowledge.
Yes. AI can be leveraged by smaller, emerging biotechnology companies for research data management, retrieval, document processing, analytical capabilities, regulatory workflows, and knowledge management.
Yes. A little smaller company can start with a narrower workflow instead of a wide enterprise platform. The scope will be specific to the data available, systems, resources and business priorities.
The length of a project can be quite variable. A proof of concept could be a smaller proof of concept that lasts less time than a production system of multiple data sources, integrations, validation activities, security controls, and governance requirements.
Yes. ZechionAI can design an engagement along a clear, specific pilot with a workflow, data set, user group, evaluation criteria, and success measure.
Requirements are user case specific. Data can be documents, structured data, metadata, system records, APIs, approved repositories or other approved sources.
Yes, if it is technically possible. The goal might be to embed into existing infrastructure instead of needless replacement of established infrastructure.
Yes. Custom applications can integrate AI models, data pipelines, document processing, enterprise integration, workflow automation, search, dashboards and user interfaces.
Yes. ZechionAI can be configured with task-specific agents having set permissions, tools, workflows, data sources, review controls, and escalation rules.
The system can be programmed to reject results with low confidence or unclear answers, ask for more detail, send it to a human for review, or avoid giving a definite answer.
Exception handling can be used to send out cases when they are uncertain, incomplete, failed or unusual to specific users or queues for review, rather than automatically completing the workflow.
Elements of monitoring may be model performance, extraction quality, retrieval performance, exception rates, system availability, user feedback, workflow performance, changes of source data, etc.
Yes. Roles, groups, repositories, document classification, permissions, and security policies can be used to create access.
Yes. Role based and permission aware architectures can limit access per department/
organization if desired. AI can be used to organize documents, find relevant records, classify documents, identify requested materials, and create document review packages. The responses to and representations made in final audits remain the responsibility of the organisation and its authorised persons.
Can help to automate repetitive tasks in suitable workflows when it comes to classification, extraction, comparison, summarization, routing, search, and data entry. The reduction should be based on their organisation's baseline.
There are agreed KPI's that can be used to measure value including processing time, manual effort, workflow cycle time, exception rate, search time, reporting time, adoption, and cost per document processed.
Outsourcing can give a company specialized engineering capacity, data expertise, document-AI, integration support, and flexible project resources. The best way will vary depending on the internal capabilities of the organization and the needs of the project.
Yes. Managed services may involve managed monitoring, managed maintenance, managed optimization, managed knowledge base updates, integration support, technical assistance, and governance support.
Yes, if technically possible and authorisation granted. There can be a number of different integrations, ranging from APIs, middleware, data pipelines, enterprise applications, repositories, and other methods.
Yes. One can take a phased approach starting with a single validated workflow and then branch out into more use cases once the organization assesses performance, adoption, risk and value.
ZechionAI highlights the control of access to the data, overseeing it, its evaluation, traceability, governance, monitoring, documentation, security, and appropriate validation. AI-generated output is not intended to be a replacement for regulatory, medical, scientific, safety or quality determinations.

Need a Pharmaceutical Workflow With Excessive Manual Task?
You might already have the information, files, systems and knowledge you need within your teams. The challenge can be the efficient organisation, search, analysis and movement of these resources through the appropriate workflows.
Talk to Zech, live



